Both strategies have been shown to increase survival rates since 2003 [24,25]. bendamustine are the most relevant. Regrettably, these clinical tests have included only individuals with symptomatic FL. The results of a recently reported medical trial display that treatment with single-agent rituximab prolongs progression-free survival rates, time to fresh treatment […]
Daily Archives: March 4, 2023
1 post